Task: Answer the multiple choice question.
Question: Which drug exhibits a 18.884% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. C/C(=N/NC(=O)CNC(=O)C1COc2ccccc2O1)c1ccc2c(c1)OCCO2
b. COc1ccc(CCCNC(=O)C2CCC(=O)N(CCCN3CCCC3=O)C2)cc1
c. c1cncc(-c2nc(NCC3CCCO3)c3ccccc3n2)c1
Answer: b. COc1ccc(CCCNC(=O)C2CCC(=O)N(CCCN3CCCC3=O)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCCNC(=O)C2CCC(=O)N(CCCN3CCCC3=O)C2)cc1
COc1ccc(CCCNC(=O)C2CCC(=O)N(CCCN3CCCC3=O)C2)cc1
N-[3-(4-methoxyphenyl)propyl]-6-oxo-1-[3-(2-oxopyrrolidin-1-yl)propyl]piperidine-3-carboxamide